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Mode of action 
Adverse outcome pathway (AOP) 
A B S T R A C T   
A number of human biomonitoring (HBM) studies have presented data on exposure to hexavalent chromium [Cr 
(VI)] and cadmium (Cd), but comparatively few include results on effect biomarkers. The latter are needed to 
identify associations between exposure and adverse outcomes (AOs) in order to assess public health implications. 
To support improved derivation of EU regulation and policy making, it is of great importance to identify the most 
reliable effect biomarkers for these heavy metals that can be used in HBM studies. In the framework of the 
Human Biomonitoring for Europe (HBM4EU) initiative, our study aim was to identify effect biomarkers linking 
Cr(VI) and Cd exposure to selected AOs including cancer, immunotoxicity, oxidative stress, and omics/epige-
netics. A comprehensive PubMed search identified recent HBM studies, in which effect biomarkers were 
examined. Validity and applicability of the markers in HBM studies are discussed. The most frequently analysed 
effect biomarkers regarding Cr(VI) exposure and its association with cancer were those indicating oxidative stress 
(e.g., 8-hydroxy-2’-deoxyguanosine (8-OHdG), malondialdehyde (MDA), glutathione (GSH)) and DNA or chro-
mosomal damage (comet and micronucleus assays). With respect to Cd and to some extent Cr, β-2-microglobulin 
(B2-MG) and N-acetyl-β-D-glucosaminidase (NAG) are well-established, sensitive, and the most common effect 
biomarkers to relate Cd or Cr exposure to renal tubular dysfunction. Neutrophil gelatinase-associated lipocalin 
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(NGAL) and kidney injury molecule (KIM)-1 could serve as sensitive biomarkers of acute kidney injury in 
response to both metals, but need further investigation in HBM studies. Omics-based biomarkers, i.e., changes in 
the (epi-)genome, transcriptome, proteome, and metabolome associated with Cr and/or Cd exposure, are 
promising effect biomarkers, but more HBM data are needed to confirm their significance. The combination of 
established effect markers and omics biomarkers may represent the strongest approach, especially if based on 
knowledge of mechanistic principles. To this aim, also mechanistic data were collected to provide guidance on 
the use of more sensitive and specific effect biomarkers. This also led to the identification of knowledge gaps 
relevant to the direction of future research.   
1. Introduction 
Human biomonitoring (HBM) assesses human exposure to chemicals 
and pollutants by analysing these substances, their metabolites or re-
action products in blood, urine, saliva, placenta, breast milk, faeces, hair 
and nails. Regarding metal and metalloid species, blood, urine and hair 
are the most widely accepted biological matrices to measure their cu-
mulative body burden (CDC, 2005; Gil and Hernández, 2015). HBM 
allows for taking into account lifestyle factors and individual suscepti-
bilities, which helps to identify subpopulations at risk. Additionally, it 
enables the identification of spatial and temporal trends in exposure and 
to detect exposure-health relationships. HBM is also a valuable tool for 
the detection of emerging pollutants. The evidence gathered through 
HBM can contribute to human health risk assessment of chemicals 
(Louro et al., 2019), to priority setting of actions and measures for 
policy-making, to assessing the effectiveness of implemented environ-
ment and health policies in reducing exposure to hazardous substances, 
and to evaluating more comprehensively the impact of policy measures 
on human health (Joas et al., 2012; Ganzleben et al., 2017). 
The Human Biomonitoring Initiative for Europe (HBM4EU, www. 
hbm4eu.eu), involving 30 European countries, the European Environ-
ment Agency (EEA) and the European Commission, surveys the actual 
exposure of citizens to chemicals and environmental pollutants, in order 
to support policy-making and to minimize adverse health outcomes. The 
heavy metals hexavalent chromium [Cr(VI)] and cadmium (Cd), clas-
sified by the International Agency for Research on Cancer (IARC) as 
group 1 carcinogens (IARC 2012), are included as priority substances 
within HBM4EU. 
Cd is a naturally occurring heavy metal, which is present in small 
quantities in the environment. Human activities over the last 120 years 
have significantly increased Cd emissions (WHO 2019; ATSDR 2012). In 
addition, tobacco and food are the most important sources of exposure of 
the general population (EFSA 2009; Bocca et al., 2020). Cd is stored in 
kidney and liver with a biological half-life of 10–30 years (Järup and 
Åkesson 2009). Cd is primarily toxic to the kidney. Prolonged or high 
exposure to Cd may result in a reduced glomerular filtration rate (GFR) 
and ultimately in renal failure. Prolonged urinary levels of >4 μg Cd/g 
creatinine are associated with renal tubular dysfunction but can also 
cause bone demineralization in children (Nordberg 2009; Sughis et al., 
2011). Cd exposure may also increase the risk of osteoporosis and 
fracture in pregnant and postmenopausal women and the elderly as well 
as an increased risk of lung, endometrial, bladder and breast cancer in 
the general population (EFSA 2009; Nordberg et al., 2015; Grioni et al., 
2019). Whether human exposure at doses below 2.5 μg/kg bw/week 
(equivalent to < 1 μg Cd/g creatinine in urine) affects skeletal, renal, 
hormonal or reproductive functions is controversial (Åkesson et al., 
2014; Nordberg et al. 2015, 2018; Apostoli and Catalani 2015; Bernard 
2016; Ronchetti et al., 2016). This lack of clarity, also with regard to 
occupationally exposed persons, is the main reason for including Cd as a 
priority substance in HBM4EU. 
Cr(VI), the second most stable oxidation state of chromium, is rarely 
found in nature. Environmental exposure occurs through tobacco 
smoke, including electronic cigarette smoke (Williams et al., 2017) and 
inhalation of polluted air or ingestion of contaminated water in citizens 
living in industrial or contaminated areas (IARC, 2012). Exposure to 
environmental Cr(VI) through the oral route has been associated to 
chronic kidney disease (Kulathunga et al., 2019; Tsai et al., 2017) and 
gastrointestinal disturbances, including stomach ulcers and oral cancer 
(Zhitkovich, 2011). Even though the meta-analysis conducted by Well-
ing et al. (2015) pointed out that Cr(VI) was a stomach carcinogen for 
humans, a more recent systematic review and meta-analysis showed that 
Cr(VI) does not increase the incidence of stomach cancer (Suh et al., 
2019). 
Nevertheless, anthropogenic activities such as welding, electro-
plating, surfaces treatment and leather tanning are by far the largest 
source of Cr(VI). Occupational exposure occurs in workers involved in 
such industrial activities, the main exposure routes being dermal contact 
and inhalation of dust and mist or fumes (Elhosary et al., 2014; Lin et al., 
2019; Pan et al., 2018; Wang et al. 2011, 2012). Following inhalation, Cr 
(VI) reaches the respiratory tract and a high percentage of both solubi-
lized Cr(VI) and poorly soluble Cr particles (<5 μm) enter the blood-
stream and is distributed to nearly all tissues (ATSDR, 2008). The main 
adverse health outcomes due to chronic Cr(VI) inhalation are lung 
impairment, including pneumonia, bronchitis, asthma and lung cancer 
(Al osman et al., 2019; Saha et al., 2011). Similarly to Cd, total Cr ac-
cumulates also in human kidney, besides liver and bone tissues (IARC 
2012), increasing the risk of nephrotoxicity, among other undesirable 
effects. Despite its carcinogenic properties, the use of Cr(VI) compounds 
(chromates, chromium trioxide and dichromium tris(chromate)) for 
specific purposes is still authorized under the European regulation (EC, 
1907/2006) concerning the Registration, Evaluation, Authorisation and 
Restriction of Chemicals (REACH), raising occupational health concerns 
that have been addressed under the HBM4EU project. Due to potential 
exposure sources, converging mechanisms of action or target organs, 
co-exposure to Cd and Cr(VI) has been the subject of research in recent 
years. 
One important objective of the HBM4EU project is to demonstrate 
the value and applicability of biomarkers of biological effect, further 
referred to as ‘effect biomarkers’, to complement biomarkers of expo-
sure in HBM studies (Baken et al., 2019; Mustieles et al., 2020; Stef-
fensen et al., 2020). Effect biomarkers are physiological parameters that 
mirror an exposure-related response that is associated with an altered 
biological structure, function, or with a disease phenotype (WHO, 1993; 
NRC, 2006). These include early biochemical, cellular or molecular ef-
fects (Corradi et al., 2015) that are measurable in target or surrogate 
tissues, e.g., blood cells, and that are associated with the adverse 
outcome (AO). Thus, mechanistic information about Cr(VI) or Cd Modes 
of Action (MoA) is of utmost importance to identify the most sensitive as 
well as robust effect biomarkers, i.e., those that measure alterations 
recognized as being central to the targeted health effect. 
The framework of the Adverse Outcome Pathway (AOP) is based on a 
series of linked key events (KEs) that begins with a molecular initiating 
event (MIE) and ends in an AO. The concept allows to evaluate the 
relevance of an effect biomarker to an expected AO (Leist et al., 2017; 
OECD 2013, 2018). Concerning the MoAs, Cr(VI) and Cd likely share 
KEs at the molecular and cellular levels, involving oxidative stress and 
changes in cell redox status, inhibition of DNA repair mechanisms and 
altered regulation of gene expression that can induce genetic instability 
and disturbances of cell homeostasis. In cells, Cr(VI) is reduced to Cr(III), 
a more thermodynamically stable form of Cr. The intermediate Cr 
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species, i.e., Cr(IV) and Cr(V) are able to form DNA and DNA-protein 
adducts (e.g. DNA-amino acid cross-links) that may give rise to DNA 
single- and double-strand breaks (Stearns et al., 1995). During the 
intracellular detoxification process, reactive oxygen species (ROS) are 
also formed, which are considered to mediate Cr(VI)-induced changes in 
cell signalling and homeostasis leading to cell death by apoptosis (Chen 
et al., 2019a). ROS accumulation generates oxidative stress and 
contributes to chronic inflammation, metabolic reprogramming, and 
genetic instability, ultimately leading to tumor development (Wang 
et al., 2016; Chen et al., 2019b). The molecular toxicity of Cd also in-
volves the (indirect) induction of ROS and the reduction of cellular 
antioxidants. In addition, the inhibition of DNA repair enzymes, the 
influence on gene transcription and translation, the disturbance of the 
ubiquitin-proteasome system and the calcium homeostasis are 
Fig. 1. Results of the literature survey on (A) effect biomarkers used in HBM studies related to Cr(VI) exposure or on (B) Cr(VI) exposure and cancer.  
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recognized to mediate its toxicity. As a result, Cd can interfere with 
essential cellular processes such as proliferation, differentiation, and 
apoptosis, which may contribute to its carcinogenicity (Yu et al., 2008; 
EFSA 2009). 
To obtain an overview of the most informative effect biomarkers 
suitable for use in HBM studies on Cr(VI) and/or Cd exposed pop-
ulations, a comprehensive literature search was carried out. The most 
promising biomarkers of effect are presented and discussed considering 
the mechanism of action and specific AOs for each heavy metal. 
2. Methods 
A literature search in PubMed was conducted to identify studies 
published between 2008 and 2018 that included effect biomarkers 
associated with Cr or Cd exposures, supplemented by a targeted search 
for studies dealing with particular AOs. For Cr(VI), the focus was on 
cancer, stomach cancer, respiratory cancer and lung cancer (Fig. 1). The 
search for Cd focused on immunotoxicity, epigenetics/omics, and 
oxidative stress (Fig. 2). Initially, we did not address on nephrotoxicity, 
as effect biomarkers for this endpoint have already been widely 
described (e.g. EFSA 2009). Nevertheless, when searching for Cd and 
effect markers, we mainly found those effect markers indicating renal 
damage. As depicted in Figs. 1 and 2, numerous search terms and search 
term combinations were used, based on MeSH® terms and MeSH sup-
plementary concepts (https://www.nlh.gov/mesh). 
The selection of abstracts, after exclusion of inappropriate studies 
(non-human studies, pure environmental studies, pure exposure studies, 
publications in non-English language, commentaries, studies for the 
development of methods and identification technologies), was subjected 
to a thorough review. With the aim to link the effect biomarkers iden-
tified in the search to KEs that ultimately lead to the AOs for Cr(VI) or Cd 
exposures, articles containing mechanistic information from animal 
studies or in vitro studies were also used (Fig. 1B). 
The studies found in the literature search formed the basis for the 
review. The selected references are listed in Table 1. Where indicated, 
we have added supplementary information from other reviews and 
original papers. An additional literature search was conducted in 
February 2021 for the period 2018–2020. These new articles are sum-
marized in Suppl. Table 1 and their findings discussed when they add 
relevant information beyond that already found. 
3. Results 
Among the articles retrieved were many studies on established effect 
biomarkers, which are summarized in Table 1. Their applicability, 
clinical significance, and mechanistic relevance associated with the 
respective health outcome are also included in the table. Other effect 
biomarkers identified for both metals whose utility remains to be 
confirmed in larger populations and/or other contexts are referred to as 
candidate biomarkers. The latter are mostly associated with omics ap-
proaches and are presented in Table 2 along with some foreseeable 
advantages and limitations in their use. 
The first search for effect biomarkers applied in HBM studies 
regarding Cr(VI) exposure resulted in 1041 articles, from which 50 were 
Fig. 2. Results of the literature survey on effect biomarkers used in HBM studies related to Cd exposure.  




Effect biomarkers identified for Cr(VI) or Cd-exposed populations according to the respective literature sources (column ’References’) and their mechanistic relevance for the selected adverse health effect. The biomarkers 
are listed separately for Cr(VI) and Cd.  
Biomarker of effect Mechanistic relevance and link with health outcome References 
Cr(VI) Genotoxicity 
Chromosome alterations (Micronucleus or  
chromosome aberrations in peripheral blood  
lymphocytes or micronucleus in buccal cells) 
Cr(VI) induces DNA damage either mediated by reactive oxygen species (ROS) from its intracellular reduction, by interacting with proteins or 
with DNA (Wedrychowski et al., 1985; DeLoughery et al., 2015), or through interferences with DNA repair systems causing DNA single- and 
double-strand breaks (DSBs) (Christie et al., 1984; DeLoughery et al., 2015). Unrepaired or erroneously repaired DBS may give rise to 
structural chromosome anomalies, which can be experimentally assessed through chromosome aberrations or micronuclei (MN) in human 
peripheral lymphocytes (Albertini et al., 2000; Bonassi et al., 2007) or in buccal cells (for MN). The frequencies of chromosome aberration or 
micronucleated cells have been used as effect biomarkers in heavy metals- exposed populations (Annangi et al., 2016) and are known to be 
associated with cancer risk (Bonassi et al., 2007; Bofetta et al., 2007). 
Balachandar et al. (2010) 
Angelieri et al. (2011) 
Xiaohua et al. (2012) 
Sudha et al., (2011) a 
Li et al. (2014) 
Li et al. (2016) 
Yang et al. (2016) 
Wultsch et al., (2017) b 
Franken et al., (2017) a,c 
DNA damage (Comet assay in leukocytes or  
buccal cells; DNA-protein crosslinks) 
Different types of DNA damage have been identified following exposure to Cr(VI) and have been implicated in its genotoxicity both in vivo 
and in vitro: DNA strand breaks, inter-strand cross-links and DNA adducts. Using UvrABC nuclease and formamidopyrimidine glycosylase 
(Fpg), and ligation-mediated PCR methods, Arakawa et al. (2012) suggested that inside of the cells, Cr(VI) and Cr(V) interact with adenines 
and guanines of genomic DNA to cause bulky DNA adducts (e.g., GSH-Cr-DNA) and oxidative DNA damage, which are poorly repaired. Fang 
et al. (2014) showed the ability of Cr(VI) to intercalate between DNA basepairs (Fang et al., 2014). 
Unrepaired lesions can lead to mutation formation and, subsequently, to cancer development. The comet assay is one of the most used effect 
markers in human biomonitoring studies to measure DNA damage; its modification with the Fpg enzyme allows the additional detection of 
oxidative DNA damage. The information obtained can lead to individual advice on relative risks of genotoxic exposure to environmental or 
occupational stressors (Dusinska and Collins, 2008). 
Grass et al. (2010) d,e 
Balachandar et al. (2010) 
Sudha et al., (2011) a 
Zhang et al. (2011) 
Franken et al., (2017) c 
Mutation frequencies of T-cell receptor  
(TCR-Mf) 
Cr(VI) exposure induces directly and indirectly (via ROS) DNA lesions that, if unrepaired, may result in increased levels of mutations in 
somatic cells. The T-Cell Receptor (TCR) mutation assay measures the mutation frequencies of T-cell receptor in somatic cells and has been 
used in biomonitoring studies to predict the cancer risk following exposure to ionizing radiation (Taooka et al., 2006) or metal(loid)s (Coelho 
et al., 2013) exposure. 
Coelho et al., (2013) f 
Cr(VI) Oxidative stress 
8-hydroxy-2’-deoxyguanosine (8-OHdG)r One of the major mechanisms that mediate Cr(IV)-induced cellular damage is ROS generation following binding of ROS scavengers (e.g., 
glutathione and ascorbate) to Cr(VI) and Cr(III) and their reduction to Cr(V) and Cr(IV). Free radicals such as the hydroxyl radicals are able to 
react with guanine residues and generate DNA adducts. Among these, 8-OHdG has been recognized as a relevant exposure and effect 
biomarker not only for oxidative damage associated with Cr(VI) exposure (and also Cd exposure; Huang et al., 2009) but with mutagenicity 
and cancer development (Valko et al., 2004; Chen et al., 2019 a, b). Measurement of urinary 8-OHdG can be carried out using 
high-performance liquid chromatography with tandem mass spectrometry (Pan et al., 2018) and other methods. 
Zhang et al. (2011) 
Ni et al., (2014) g 
Pizzino et al., (2014) h 
Pesh et al. (2015) 
Wang et al. (2015) 
Franken et al., (2017) c 
Savarino et al., (2017) i 
Pan et al. (2018) 
Lipid peroxidation (LPO)r 
Malondialdehyde (MDA)r 
MDA is the major product of polyunsaturated fatty acid peroxidation, a metabolic process of oxidative deterioration of lipids within the cell 
membrane that is catalysed by iron. This aldehyde is a highly toxic molecule that can react with DNA bases guanine, adenine, and cytosine to 
form premutagenic adducts (Jomova and Valco, 2011). It has been widely used as a biomarker of lipid peroxidation in epidemiological 
studies of Cr(VI) exposure. 
Khan et al. (2012) 
Serafim et al., (2012) j 
Ambreen et al. (2014) 
Zendehdel et al. (2015) 
Bibi et al. (2016)k 
Gube et al. (2010) 
Khan et al. (2012) 
Ambreen et al. (2014) 
Elhosary et al. (2014) 
Jamilian et al. (2016) 
Mozafari et al. (2016) 
Nascimento et al. (2017) 
Pan et al. (2018) 
Glutathione (GSH)r In the intracellular moiety Cr(VI) reacts with glutathione, which is a substrate for several enzymes that remove ROS and is also a powerful 
cellular antioxidant, giving rise to Cr(V). Likewise, Cr(VI) and then Cr(IV) become reduced to the next lower oxidation state by reacting with 
GSH while the latter become oxidized to glutathione disulfide (GSSG). In lung cells, ascorbate is the most important Cr(VI) reductant, 
although GSH also plays an important detoxification role. The risk of lung cancer increases when Cr(VI) doses overwhelm the cellular defence 
mechanisms (Jomova and Valco 2011). Low GSH concentrations and a high GSSG:GSH ratio have been measured in blood of patients with 
various diseases, including breast and lung cancer. The GSH system is also altered in lung inflammatory conditions and GSH concentrations in 
Khan et al. (2012) 
Ambreen et al. (2014) 
Bergamo et al., (2016) l 
(continued on next page) 
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Table 1 (continued ) 
Biomarker of effect Mechanistic relevance and link with health outcome References 
the epithelial lining fluid are decreased in idiopathic pulmonary fibrosis, asbestosis and acute respiratory distress syndrome (Comhair et al., 
2002). 
Glutathione peroxidase (GPx)r 
Superoxide dismutase (SOD)r 
Enzymatic antioxidants can intercept, scavenge and neutralize ROS, and can reactivate intermediates generated in excess under physiological 
conditions. The most important antioxidant enzymes are SOD, catalase, and the glutathione redox system (glutathione peroxidase and 
glutathione-S-transferase) (Valko et al., 2007). The activity of selected antioxidant enzymes has been measured in blood samples as 
biomarkers of oxidative stress linked to Cr(VI) exposure. 
Bibi et al. (2016)k 
Khan et al. (2012) 
Ambreen et al. (2014) 
Prostaglandin E2 (PGE2) in exhaled breath  
condensate 
8-iso-prostaglandin-F2α (8-iso-PGF2α) in  
urine 
8-iso-PGF2α is an isoprostane (IsoPs) produced by the non-enzymatic peroxidation of arachidonic acid in membrane phospholipids. It has 
been considered as a reliable biomarker of lipid peroxidation. At present, measurement of F2-IsoPs in plasma or urine is regarded as one of the 
most reliable approaches for the assessment of oxidative stress status or free-radical–mediated lipid peroxidation in vivo and thereby it may be 
a reliable effect biomarkers for Cr(VI) (Dalle-Donne et al., 2006; Wang et al., 2015). Furthermore, 8-iso-PGF2α is markedly increased, serving 
as a biomarker, in the bronchoalveolar lavage (BAL) fluid, plasma, urine, or exhaled breath condensate in several pulmonary diseases such as 
asthma, and interstitial lung disease, among others (Dalle-Donne et al., 2006). 
Grass et al., (2010) d 
Hoffmeyer et al., (2012) m 
Wang et al., (2015) n 
Thiol antioxidants Thiols are anti-oxidant molecules in the sulfhydryl group that can be found in plasma (albumin thiols, protein thiols and cysteine, 
cysteinylglycine, glutathione, homocysteine and γ-glutamylcysteine). Oxidation reaction of thiols with oxidizing molecules causes the 
formation of reversible disulphide bonds that can again be reduced to thiol groups. Dynamic thiol-disulphide homeostasis plays an important 
role in anti-oxidant defense, detoxification, and apoptosis, among others (Baba and Bhatnagar 2018). Serum and plasma levels of total thiol 
(SH groups) were lower in Cr(VI) exposed workers as compared to controls and correlated negatively with oxidative stress. 
Pournourmohammadi et al., (2008) o 
Elhosary et al. (2014) 
Zendehdel et al. (2015) 
Total antioxidant capacity (TAC) Several assays that determine the ability of a biological sample to reduce a substrate, for instance through hydrogen atom transfer or electron 
transfer reactions, as measuring the ability of serum to reduce Fe3+ to Fe2+ or Cu2+ to Cu+. Serum levels of TAC were lower in cement 
industry workers as compared to controls. TAC was also lower in seminal plasma of males living in areas high polluted with toxic waste, but 
not in their blood. Cr supplements in women with polycystic ovary syndrome resulted in a significant elevation of plasma TAC. 
Pournourmohammadi et al., (2008) o 
Zendehdel et al. (2015) 
Jamilian et al. (2016) 
Nitrate and nitrite in exhaled breath condensate Production of nitric oxide (NO) is generally increased during inflammation and eventually is oxidated to nitrite (NO2) and nitrate (NO3), both 
of which are end-products of NO metabolism. Increased in welders. 
Gube et al. (2010) 
Brand et al. (2010) 
Cd Oxidative stress 
Glutathione peroxidase (GPx)r, glutathione (GSH)r,  
Selenium 
Cadmium is not a Fenton metal and therefore is unable to directly generate free radicals. However, some studies described indirect formation 
of ROS and RNS involving the superoxide radical, hydroxyl radical and nitric oxide. In rats exposed to Cd through drinking water significantly 
increased lipoperoxides, MDA and decreased activities of SOD and GPx were found in cardiac tissue (reviewed in Jomova and Valko 2011). 
Cabral et al. (2015) 
Protein carbonylation of GPx, glutathione  
reductase (GR), superoxide dismutase  
(SOD)rand catalase (CAT) 
Castillo-Castaneda (2017) 
Lipid peroxidation (e.g., MDA)r Castillo-Castaneda (2017) 
Cuypers et al. (2010) 
Cd Nephrotoxicity 
Urine β2-microglobulin (B2-MG)r B2-MG is a small protein of about 12 kDa necessary for cell surface expression of major histocompatibility factor (MHC) class I molecules and 
other (non-classical MHC-1) proteins such as hemochromatosis. It circulates in a soluble form in blood entirely reabsorbed by the nephron. 
Serum levels rise when glomerular filtration is impaired, while urinary levels increase when tubular reabsorption is harmed. Thus, urinary 
B2-MG may be a marker for glomerular rather than of tubular pathology (Grangé et al., 2016; Argyropoulos et al., 2017). B2-MG is 
recommended as marker of chronic kidney disease (CKD)(Foster et al., 2016; Tummalapalli et al., 2016). CKD lasts for at least 3 months and 
is often an irreversible defect (Kaufman et al., 2019). Cd concentrations in urine, when adjusted for creatinine, age, sex, and smoking are 
associated with B2-MG in ten studies retrieved by our search (see right column for references). 
Nordberg et al. (2009) 
Trzcinka-Ochocka et al. (2010) 
Ikeda et al. (2011) 
Swaddiwudhipong et al., (2012), 
2015 
Nishijo et al. (2014) 
Ke et al. (2015) 
Zhang et al. (2015) 
Wang et al. (2016) 
Eom et al. (2017) 
N-acetyl-β-D-glucosaminidase (NAG)r NAG is a large lysosomal brush border enzyme (>130 kDa) of the proximal tubular cells, stably present in urine. Plasma NAG cannot be 
filtered through the glomerular membrane and its increase in urine is exclusively caused by proximal tubular cell injury. NAG is defined as 
being more specific and sensitive to renal tubular injury than creatinine especially with its isoenzymes and when combined with other renal 
biomarkers, for example Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1) (Çuhadar and Semerci 
2016; Moriguchi et al., 2009; Argyropoulos et al., 2017). NAG is among the best characterized markers and proven to be a sensitive and 
robust indicator of acute kidney injury (AKI) (Ferguson et al., 2008). AKI is an abrupt increase in serum creatinine - generally over days - and 
is largely reversible (Kaufman et al., 2019). Cd concentrations in urine, when adjusted for creatinine, age, sex, smoking and other 
study-specific factors (e.g. concurrent Pb exposure), are associated with NAG in ten studies (see right column for references). 
Huang et al. (2009) 
Trzcinka-Ochocka et al. (2010) 
Boonprasert et al. (2011) 
Ikeda et al. (2011) 
Nordberg et al. (2009) 
Hambach et al. (2013) 
Nishijo et al. (2014) 
Zhang et al. (2015) 
Wang et al. (2016) 
Eom et al. (2017) 
Retinol binding protein (RBP) RBP is a low molecular weight protein belonging to the lipocalin super family. Its main function is to transport retinol (vitamin A). The 
majority of RBP-retinol circulates in the plasma bound to transthyretin, a complex that prevents its glomerular filtration. 4–5% of serum RBP- 
(continued on next page) 
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Table 1 (continued ) 
Biomarker of effect Mechanistic relevance and link with health outcome References 
retinol, however, circulates freely, pass the glomerular barrier and is then reabsorbed and degraded in the proximal tubule, a process 
mediated by megalin. Due to these properties, urinary RBP is an established biomarker of proximal tubular dysfunction and is used as a 
diagnostic tool in proximal tubulopathies (Domingos et al., 2016). Cd concentrations in urine, when adjusted for creatinine, age, sex, smoking 
and other study-specific factors (e.g. concurrent Pb exposure), are associated with RBP in three studies (see right column for references). 
Trzcinka-Ochocka et al. (2010) 
Hambach et al. (2013) 
Zhang et al. (2015) 
Glomerular filtration rate (GFR) GFR represents the flow of plasma from the glomerulus into Bowman’s space over a specified period. It is the main measure of kidney function 
calculated from blood creatinine and/or Cystatin-C (Cys-C) in conjunction with age, body size and gender. Combining serum creatinine and 
Cys-C are superior to equations using either Cys-C or serum creatinine alone (Wasung et al., 2015). Changes in GFR are used to define and 
diagnose several pathologies. 
In three studies Cd levels in urine are inversely correlated with GFR (Weaver et al., 2011; Swaddiwudhipong et al., 2012; Eom et al., 2017). 
Weaver et al. (2011) 
Swaddiwudhipong et al. (2012) 
Eom et al. (2017) 
Tsai et al. (2017) 
Wu et al. (2018) 
Urine albumin Urine albumin serves as a specific and stable biomarker for the early diagnosis of AKI. The combination of creatinine, Cystatin-C and urinary 
albumin to creatinine ratio enhances risk stratification for kidney disease progression and mortality (Wasung et al., 2015). Much higher levels 
of urinary albumin are observed with glomerular injury than with tubular injury. In rodents, albuminuria is a marker of cisplatin 
nephrotoxicity. Cisplatin increases albuminuria, but the clinical relevance is uncertain. The low costs of commercially available tests for the 
detection of urine albumin is an advantage for routine clinical use. Nonetheless, a panel of biomarkers would be necessary to identify the 
severity of injury and the type of insult (Bolisettyand Agarwal 2011; Griffin et al., 2019). Two studies found urinary Cd associated with urine 
albumin. 
Trzcinka-Ochocka et al. (2010) 
Nordberg et al. (2009) 
Urine total protein In one study, urinary total protein was associated with urine Cd levels (Swaddiwudhipong et al., 2012) Swaddiwudhipong et al., (2012), 
2015 
Urine α₁-microglobulin (A1-MG) Urinary A1-MG offers a non-invasive, cost-effective diagnostic alternative for the early detection of tubular diseases caused by e.g. heavy 
metal intoxication. The 27-kDa glycoprotein, whose exact biological function is unknown, is found in various body fluids. Altered plasma/ 
serum levels are usually due to impaired liver or kidney function, but are also observed in clinical conditions such as HIV (Penders and 
Delanghe 2004). 
Ikeda et al. (2011) 
Cr(VI) Nephrotoxicity 
Kidney injury molecule-1 (KIM-1) KIM-1 is strongly upregulated in the proximal tubule cells after AKI. Its ectodomain is secreted into the lumen and serves as a urinary 
biomarker. KIM-1 also acts as a blood biomarker specifically reflecting AKI (Prozialeck and Edwards 2012; Sabbisetti et al., 2014). 
Cárdenas-González et al. (2016)p 
Cystatin C (Cys-C) Cys-C is a marker of the GFR. It is a low molecular weight protein and a potent cysteine protease inhibitor. The plasma concentration of 
Cystatin-C is proportional to glomerular filtration, making it ideal for GFR estimation. The protein has the ability to detect early renal failure 
as it provides a reliable GFR estimate at critical values. For this reason, Cys-C is regarded superior to serum creatinine. Also Cd increases the 
urinary excretion of Cys-C in rats (Prozialeck et al., 2016). 
Wang et al. (2011) 
Urine β2-microglobulin (B2-MG)r See information related to Cd nephrotoxicity Wang et al. (2011) 
Li et al. (2015)Cárdenas-González 
et al. (2016) 
p 
N-acetyl-beta-D-glucosaminidase (NAG)r See information related to Cd nephrotoxicity Wang et al. (2011)Cárdenas-González 
et al. (2016) 
p 
Cd Immunotoxicity/inflammatory effect 
Values of blood counts Alterations of values of blood counts, i. e. values of neutrophils and lymphocytes, are regarded as a marker of early immunotoxicity. Ciarrocca et al. (2015) 
Altered distribution of T cell populations Shifts of T-cell subpopulations as innate elements of the immune system are markers of early immunomodulatory effects. Altered distribution 
of T cell populations at birth could cause immunosuppressive effects observed later in childhood (Nygaard et al., 2017). 
Nygaard et al. (2017) 
Ohsawa et al. (2009) 
Induction of autoantibodies Associated to polyclonal B cell activation, T-cell mediated immunostimulation via cytokines and recognition of MHC-II antigens of cell 
surface including induction of autoantibodies was found to be the primary immunotoxic effect of Cd and can be linked to autoimmune 
diseases (Ohsawa et al., 2009). 
Ohsawa et al. (2009) 
Cr(VI) Immunotoxicity/inflammatory effect 
High-sensitivity C-reactive protein (hs-CRP) CRP is an acute phase protein synthesized by the liver in response to interleukin-6 secretion by macrophages and T cells, being a nonspecific 
biomarker of inflammation. Serum Hs-CRP was significantly elevated in Cr(VI)-exposed workers. 
Jamilian et al. (2016) 
Wang et al. (2012) 
Lymphocyte induced proliferation This assay evaluates the proliferative response of lymphocytes, and is usually performed in the presence of a mitogen, a polyclonal activator 
of lymphocytes that stimulates their proliferation (lymphocyte mitogen-induced proliferation). It is used to evaluate the subject cell- 
mediated immune responsiveness. The lymphocyte proliferative response to mitogens was higher in shoe, hide, and leather industry workers 
exposed to Cr(VI). Lymphocytes of Cr allergic contact dermatitis patients were also stimulated by Cr, but in this case the lymphocyte 
proliferative response had low sensitivity. 
Mignini et al. (2009) 
Glucocorticoid receptors (GR) on peripheral blood 
mononucleate cells (PBMC) 
Mignini et al. (2009) 
(continued on next page) 
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Table 1 (continued ) 
Biomarker of effect Mechanistic relevance and link with health outcome References 
GR are ubiquitously expressed nuclear receptors to which cortisol and other glucocorticoids bind. Glucocorticoids are steroid hormones 
involved in several physiological functions and in controlling inflammation (Scheschowitsch et al., 2017). GR density on PBMC were lower in 
exposed workers versus controls indicating that Cr(VI) is probably an immunological stressor. 
Cytokines (Interleukins IL-2, IL-5, IL-6, IL-12  
and IL-13) and interferon-gamma (IFN-γ) 
Cytokines are small, secreted proteins released by cells having a specific effect on the interactions and communications between cells. There 
are both anti- and pro-inflammatory cytokines. The latter are produced predominantly by activated macrophages and involved in the up- 
regulation of inflammatory reactions (Zhang and An, 2007). IL-2, IL-5, IL-6 and IL-12 are pro-inflammatory cytokines that were raised upon 
Cr exposure, as well as IFN-γ.IFN-γ is primarily secreted by activated T cells and natural killer cells, and can promote macrophage activation, 
mediate antiviral and antibacterial immunity, enhance antigen presentation, orchestrate activation of the innate immune system, coordinate 
lymphocyte–endothelium interaction, regulate T helper1/T helper 2 activity of CD4+ T cells balance, and control cellular proliferation and 
apoptosis (Tau and Rothman 1999). IL-13, a mediator of allergic inflammation, showed higher levels in Cr allergic contact dermatitis 
patients. 
Martins and Reis (2013) 
Club (Clara) cell protein (CC16) and  
surfactant-associated protein D (SP-D) CC16 
CC16, as an immunosuppressive protein, and CC16/SP-D were positively associated with indicators of lung injury and can be used as 
sensitive serum biomarkers for lung toxicity caused by Cr(VI) exposure. 
Li et al. (2015) 
Cd or Cr(VI) Other biomarkers/effects q 
Blood pressure (Cd) Altered blood pressure is commonly associated with cardiovascular disease. Boonprasert et al. (2011) 
Osorio-Yañez et al. (2016)  
Swaddiwudhipong et al. (2015) 
Bone demineralization (urinary calcium,  
deoxypyridinoline (DPD)) (Cd) 
Urinary calcium excretion is a determinant of bone mineral density. Deoxypyridinoline (DPD) represents a specific degradation product of 
mature collagen found in bones. It is excreted unmetabolized in urine and is a specific marker of bone resorption and osteoclastic activity. 
Two studies found urinary Cd concentrations associated with B2-MG, U-Ca and DPD levels. 
Sughis et al. (2011) 
Eom et al. (2017) 
Bone mass density (Cd) Decreasing bone mass density is associated with cadmium-induced bone disorders. Trzcinka-Ochocka et al. (2010) 
Increased susceptibility to chronic infections (Cd) Commonly linked to reduced immune functions. Krueger and Wade (2016) 
Serum folate level (Cr(VI)) Long-term Cr (VI) exposure has been associated with decreased serum folate, an essential vitamin, and a cofactor in one-carbon metabolism ( 
Wang et al. 2011, 2012). Epidemiological and experimental evidences have shown that folate deficiency may be implicated in cancer 
development, e.g., lung and colorectum cancer (Ozkan et al., 2007) and thereby serum folate level is a promising marker of early Cr(VI) 
effects that needs, however, to be further studied. 
Wang et al., (2011), 2012  
a Analysed in buccal exfoliated cells. 
b Occupational exposure to chromium and cobalt. 
c Environmental exposure to potentially carcinogenic compounds, including chromium, cadmium, nickel, arsenic, PAHs, benzene, pesticides, etc. 
d Occupational exposure to chromium, iron, and manganese. 
e DNA-protein crosslinks measured in blood lymphocytes. 
f Environmental or occupational co-exposure to metal(loids) including cadmium, chromium, arsenic, manganese, nickel, lead, and selenium. 
g Occupational co-exposure to cadmium, chromium, lead, and nickel. 
h Environmental co-exposure to chromium and cadmium. 
i Chromium and cobalt exposure in patients with metal-on-metal hip resurfacing. 
j Environmental exposure to chromium, cadmium, lead, copper, nickel, and zinc. 
k Environmental exposure to chromium, cadmium, lead, copper, nickel, cobalt, manganese, iron, and zinc. 
l Environmental exposure to toxic waste; biomarkers measured in semen. 
m Occupational exposure to chromium, iron and nickel. 
n Occupational exposure to chromium, cadmium, arsenic, lead and nickel. 
o Occupational exposure to chromium and aluminium. 
p Environmental exposure to chromium and arsenic. 
q Biomarkers identified during the literature search that were not associated with the selected health effects. These biomarkers were included because they may provide additional useful information. 
r Biomarker reported for Cr(VI) or Cd exposure. 
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eligible (Fig. 1A). One of these articles was excluded afterwards because 
it consisted of a re-analysis of pre-existent data. The literature searches 
on Cr(VI)-associated cancer resulted in 173 articles either after using the 
search terms “Cr(VI)” and “cancer” or after more targeted queries for Cr 
(VI) and stomach cancer (10), respiratory cancer (29) and lung cancer 
(51); from these, 117 were considered eligible (Fig. 1B). Out of these, 26 
studies were observational, 3 were data modelling or meta-analyses, and 
88 were experimental, using either mammalian cell lines (42 articles), 
animal models (41 articles) or both (5 articles). Those in vitro and in vivo 
studies reporting mechanistic information about Cr(VI) were selected 
for a more detailed analysis (Fig. 1B). With respect to Cd, a total of 582 
articles were found, of which 81 publications were eligible (Fig. 2). 
Relevant information on effect markers for oxidative stress (3 articles), 
nephrotoxicity (32 articles), and immunotoxicity (3 articles) is sum-
marized in Table 1. Seven more articles provided information on addi-
tional markers, which were included in Table 1. 
Most biomarkers analysed in the epidemiological studies on Cr(VI) 
exposure targeted oxidative stress (Table 1). For example, 9 out of the 49 
articles selected for a full text analysis reported significantly high levels 
of 8-hydroxy-2’-deoxyguanosine (8-OHdG) and eight of malondialde-
hyde (MDA), three reported depletion of glutathione (GSH) and three 
showed a depletion of superoxide dismutase (SOD). Additionally, bio-
markers of genetic damage in blood cells were also frequently used. 
Regarding Cd, most of the biomarkers retrieved by this search were 
related to nephrotoxicity and some to oxidative stress and immunotox-
icity (Table 1). 
4. Discussion 
4.1. Established effect biomarkers 
4.1.1. Cr(VI) exposure, genotoxicity and cancer 
Since Cr(VI) is known to induce, either directly or indirectly via 
oxidative stress, DNA strand-breaks and, consequently, chromosomal 
alterations, these endpoints have been frequently analysed (9 out of 49 
studies) in workers performing several activities, e.g., electroplating, 
welding, and leather tanning (Table 1). Two non-occupational studies, 
one in patients undergoing fixed orthodontic therapy (Angeleri et al., 
2011) and another one in adolescents (Franken et al., 2017) included the 
characterization of chromosome damage (micronuclei in exfoliated cells 
from oral mucosa) or DNA damage (comet assay), respectively. The 
analysis of micronuclei in cytokinesis-blocked lymphocytes was 
included in the majority of these studies (Balachandar et al., 2010; 
Xiaohua et al., 2012; Li et al. 2014, 2016; Sudha et al., 2011), frequently 
in combination with the assessment of DNA damage (Balachandar et al., 
2010; Sudha et al., 2011) or oxidative damage (e.g., 8-OHdG) (Li et al. 
2014, 2016). Notably, the frequency of micronuclei in lymphocytes was 
significantly increased in all studies and, in some of them, correlations 
were established with exposure biomarkers (Xiaohua et al., 2012; Zhang 
et al., 2011). Some studies have also reported an increase of DNA strand 
breaks in lymphocytes of workers exposed to Cr(VI) (Zhang et al., 2011). 
Franken et al. (2017) reported a positive association between bio-
markers of exposure to Cr and the levels of both 8-OHdG in urine and 
DNA damage in blood cells from the adolescent population of Flanders. 
Balachandar et al. (2010) combined the analyses of chromosome aber-
rations, micronuclei and DNA damage (comet assay) in peripheral blood 
cells and found a higher degree of genetic alterations in 72 Cr 
(VI)-exposed subjects (36 occupationally exposed in leather tannery 
industries and 36 environmentally exposed due to their residence in the 
vicinity of tannery industries) compared to non-exposed individuals. An 
increase in micronuclei frequency was also detected in cytological 
smears of tobacco user’s tannery workers (Kamil et al., 2019), but it was 
not observed in epithelial nasal or buccal cells neither in patients un-
dergoing fixed orthodontic therapy (Angeleri et al., 2011) nor in chrome 
plating workers (Wultsch et al., 2017). The mutation frequency of T-cell 
receptor (TCR) was included in a study. This is not a widely adopted 
effect biomarker and thereby its value has not been proven, although 
gene mutations are frequent events in malignant cells. Overall, these 
studies evidenced a clear genotoxic effect associated with Cr(VI) expo-
sure, and confirm the high sensitivity of genotoxicity biomarkers for the 
biomonitoring of exposed groups in occupational settings. Not surpris-
ingly, test methods for measuring chromosome aberrations, micro-
nuclei, and DNA strand breaks (comet assay) have been adopted as 
OECD Test Guidelines (OECD TGs 474, 475, 489). It is well-accepted 
that genetic damage will eventually lead to cancer; hence, safety 
testing strategies for carcinogenic effects in chemical risk assessment are 
usually based on proving absence of genotoxic potential (Luijten et al., 
2016). Indeed, an increased chromosome breakage or micronuclei fre-
quency in human blood cells (usually lymphocytes) has been associated 
with increased cancer risk (Bofetta et al., 2007; Bonassi et al., 2011). A 
similar association has not been demonstrated for the comet assay in 
human blood cells, yet. 
4.1.2. Cd or Cr(VI) exposure and nephrotoxicity 
Most of the identified effect biomarkers were related to nephrotox-
icity at urinary concentrations >4 μg Cd/g creatinine (Table 1) (Nord-
berg et al. 2015, 2018). Associations reported at lower urinary Cd levels 
(<1 μg/g creatinine) are insofar questionable as various confounding 
factors (renal physiology, diuresis, smoking), may lead to non-causal 
positive associations. Therefore, blood rather than urine markers were 
suggested as a better alternative for future studies to assess 
Cd-associated health risks (Bernard 2016, Stajnko et al., 2017). 
A single biomarker is rarely sufficient to clearly define a certain 
pathological condition of the kidney (Ferguson et al., 2008; Ostermann 
et al., 2020a). It is recommended to use sets of biomarkers to diagnose 
acute kidney injury (AKI) that is reversible in many cases, acute kidney 
disease (AKD), and chronic kidney disease (CKD) (for clinical definition 
of kidney disease see Ostermann et al. (2020b)). Neutrophil 
gelatinase-associated lipocalin (NGAL) and kidney injury molecule 
(KIM)-1 are among the most frequently mentioned biomarkers that 
predict AKI in an early stage (Wasung et al., 2015, Nickolas et al., 2018), 
also in newborns (Askenazi et al., 2012). NGAL, a 25 kDa glycoprotein 
produced by epithelial tissues, is excreted via glomerular filtration und 
undergoes complete reabsorption in healthy tubular cells. NGAL is a 
marker of injury not of normal function and serves also as a marker in 
diagnosis of CKD (Ronco et al., 2014). KIM-1 is a type 1 transmembrane 
protein, whose expression is markedly upregulated in proximal tubule 
cells from patients with acute tubular necrosis. Since 2002, the soluble 
form of human KIM-1 in urine has been considered a useful and early 
biomarker for AKI and renal proximal tubule injury (Han et al., 2002). 
This was confirmed in 2007 in a study of Cd-induced nephrotoxicity in 
rats in which KIM-1 appeared in urine 4–5 weeks before the onset of 
proteinuria and 1–3 weeks before the appearance of metallothionein 
(MT) and Clara cell protein (CC-16) (Prozialeck et al., 2007). Findings 
that were later substantiated by a thorough description of the potential 
underlying pathomechanisms (Prozialeck and Edwards 2012). 
Accurate markers for the diagnosis of CKD include NGAL, Cystatin C 
(marker of GFR), liver-type fatty acid protein (L-FABP; marker of tubular 
cell damage), B2-MG (marker of GFR), and serum β-trace protein (BTP; 
marker of GFR) among others (Nickolas et al., 2008; Wasung et al., 
2015; Foster et al., 2016; Tummalapalli et al., 2016). It should be noted 
that several markers such as Cystatin-C, NGAL, L-FABP, or NAG can be 
analysed in plasma as well as in urine, but the significance may vary. For 
example, plasma Cystatin-C may be a marker of GFR (i.e. a marker of 
kidney function), whereas it is detectable in urine only after tubular 
injury (Ostermann et al., 2012). 
Among the established biomarkers, B2-MG, NAG and α1-micro-
globulin (α1-MG), which is preferred over B2-MG in case of acidic urine 
(pH < 6), are the most frequently used biomarkers linking Cd exposure 
to renal tubular dysfunction (Table 1). In a recent study from China, B2- 
MG was shown to be a more sensitive marker than NAG for renal 
dysfunction, with 2.2 μg/g cr as threshold for clinical diagnosis (Li et al., 
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2020). 
While B2-MG is a small protein (12 kDa) necessary for cell surface 
expression of major histocompatibility factor (MHC) class I molecules 
and other (non-classical MHC-1) proteins such as the hemochromatosis 
(HFE) protein, NAG is a large lysosomal brush border enzyme (>130 
kDa) of the proximal tubular cells. Plasma NAG cannot be filtered 
through the glomerular membrane and its increase in urine is exclu-
sively caused by proximal tubular cell injury (Moriguchi et al., 2009; 
Argyropoulos et al., 2017). B2-MG is recommended as marker of CKD 
(Foster et al., 2016; Tummalapalli et al., 2016). NAG is proven to be a 
sensitive and robust indicator of AKI (Ferguson et al., 2008). Other 
markers of kidney malfunction in Cd-exposed populations included the 
glomerular filtration rate, creatinine, urinary albumin, urinary total 
protein, and urinary Retinol Binding Protein (RBP) that were frequently 
examined together with B2-MG and/or NAG (Nordberg et al., 2009; 
Trzcinka-Ochocka et al., 2010; Ikeda et al., 2011; Hambach et al., 2013; 
Swaddiwudhipong et al., 2015; Zhang et al., 2015; Eom et al., 2017). 
Despite its widespread use in HBM studies, surprisingly little is 
known about how Cd damages kidney cells to cause a simultaneous 
increase in e.g. NAG (regarded as marker of AKI) and B2-MG (marker of 
CKD) levels in urine. It should be noted that the complex pathophysi-
ology of kidney disease, including AKI, is poorly understood and that 
many questions regarding biomarkers used in the clinical setting remain 
unresolved (Ronco et al., 2014; Ostermann et al., 2020a). We see an 
urgent need to further research on the mechanisms underlying 
Cd-induced nephrotoxicity in order to better understand the value and 
importance of effect biomarkers in practice. It is therefore difficult to 
recommend biomarker sets for the Cd-exposed population. However, 
since early detection of kidney damage is very advantageous (as it is 
then often reversible), it could be of great benefit in future HBM studies 
to investigate sensitive markers for early kidney damage (e.g. NGAL, 
KIM-1) together with the established markers NAG and B2-MG. 
Nephrotoxicity after human environmental exposure to Cr was also 
observed in three studies (Table 1). A dose-dependent association be-
tween urinary KIM-1 across Cr exposure was found in 107 children 
living in San Luis Potosi, Mexico (mean urine Cr level was 61.7 ppb, 
higher than the biological exposure index). Other kidney injury/func-
tional biomarkers such as serum creatinine, GFR, albuminuria, and 
NGAL did not show any association with Cr(VI) exposure, confirming 
that KIM-1 could be an early and sensitive indicator of proximal tubular 
damage in children (Cárdenas-González et al., 2016). In another study, 
the nephrotoxicity of chromate after chronic occupational exposure was 
evaluated in 115 exposed workers and 60 non-exposed volunteers by 
determination of Cystatin-C in serum and microalbumin, B2-MG and 
NAG levels in urine. Either the serum or the urinary biomarkers were 
significantly increased in the chromate-exposed workers over controls 
(Wang et al., 2010). The urinary levels of B2-MG were also significantly 
increased in workers from two chromium-producing factories in China 
with high Cr exposure (Cr > 20 μg/L in blood) (Li et al., 2015). 
A few studies looked into co-exposure to Cr and Cd in relation to 
nephrotoxicity. Tsai et al. (2017) investigated the effects of co-exposure 
to Cr and Cd on renal function in 360 Taiwanese adults. They observed 
an independent association between Cr exposure and decreased renal 
function, but also evidenced that additional exposure to Cd further 
reduced the GFR. Such an additive effect on GFR was not found in 
another study with 934 participants in China (Wu et al., 2018). 
4.1.3. Cd or Cr(VI) exposure and oxidative stress 
Among the effect biomarkers identified in epidemiological studies on 
human exposure to Cr(VI), the majority targets endpoints related to ROS 
generation, antioxidant cell defence mechanisms and oxidative stress. 
The characterization of 8-OHdG, a DNA adduct formed by the reaction 
of hydroxyl radicals with guanine residues, was one of the most 
frequently used marker (Table 1) and its association with mutagenicity 
and cancer development has been recognized (Valko et al., 2004; Chen 
et al., 2019 a,b). A study that included 201 pregnant women, from which 
126 were exposed to e-waste recycling and dismantling activities, 
showed that the levels of 8-OHdG in the umbilical cord blood (UBC) of 
neonates were positively correlated to the UBC levels of Cr, suggesting 
an increase of oxidative DNA damage in neonates (Ni et al., 2014). 
Several other oxidative stress biomarkers were identified, including 
lipoperoxidation products (e.g., MDA) and the activity of several anti-
oxidant enzymes in blood (e.g., SOD), as shown in Table 1. In one study, 
including 22 cement workers exposed to Cr(VI) and 20 tannery workers 
exposed to Cr(III) the blood Cr level was correlated with the reduction of 
thiol antioxidants in plasma, and increased MDA and p53 expression 
(Elhosany et al., 2014). Induction of oxidative stress was observed in 
chrome electroplating workers by increased lipid peroxidation, 
decreased plasma antioxidant capacity and plasma total thiol (Zen-
dehdel et al., 2015). Pan et al. (2018) also found an association between 
Cr exposure and urinary 8-OHdG and MDA in electroplating workers. 
Serum concentration of MDA, activities of CAT and GSH-Px, as well as 
urinary concentration of 8-OHdG, were also higher in people living in 
contaminated rural areas of north-eastern China, and serum SOD ac-
tivity was significantly lower (Xu et al., 2018). 
In contrast, only few studies used biomarkers related to Cd exposure 
and oxidative stress, including glutathione peroxidase (GPx), selenium 
and GSH levels in blood and urine samples of Cd-exposed human sub-
jects (Cabral et al., 2015; Goyal et al., 2020; He et al., 2020). Addi-
tionally, associations of Cd exposure and lipid peroxidation, e.g., MDA, 
have been described, as well (Cabral et al., 2015; Cuypers et al., 2010; 
Krueger and Wade 2016). Castillo-Castaneda et al. (2017) found an as-
sociation between the levels of protein carbonylation in breast milk, 
induced by lead (Pb) and Cd oxidation, and the activity of GPx and 
glutathione reductase (GR), SOD and catalase. Metabolic changes 
induced by Cd, other heavy metals and PAHs were also found in 252 
subjects and linked to the oxidative stress biomarkers 8-OHdG, 
4-hydroxy-2-nonenal-mercapturic acid (HNE-MA), 8-isoprostaglandin 
F2α (8-isoPF2α), and 8-nitroguanine (8-NO2Gua), using 
two-dimensional gas chromatography time-of-flight (2D-GC-ToF) mass 
spectrometry. Urine metabolomics identified age-dependent biological 
pathways (Chen et al., 2017). 
Of particular interest is a recent work on Cd-specific induction of 
metallothionein (MT) isoforms, specifically MT1A and MT1M in Normal 
Human Urothelial Cells (McNeill et al., 2019), in contrast to a human 
placental cell line, in which Cd induced mainly the expression of MT2A 
(whereas hardly of MT1A) (Widhalm et al., 2020). 
4.1.4. Cd or Cr(VI) exposure and immunotoxicity 
Few scientific publications have addressed the effects of Cd or Cr(VI) 
on the immune system (Table 1). The results of a cross-sectional human 
health survey (NHANES data) suggested that the immunological effects 
of Cd and Pb toxicity may result in increased susceptibility to chronic 
infections (Krueger and Wade 2016) or contribute to auto-immune 
conditions leading to renal impairment (Ohsawa 2009). Several effect 
biomarkers, e.g., blood cell counts, and characterization of lymphocyte 
subpopulations have been proposed (Ciarrocca et al., 2015; Nygaard 
et al., 2017) but their utility still needs to be confirmed. Concerning the 
possible Cd effects on the immune system, a study on urban workers 
showed an association between exposure to airborne Cd and hemogram 
alterations consisting in a reduction of neutrophils and an increase of 
lymphocytes counts in blood (Ciarrocca et al., 2015). Also, a relationship 
between prenatal exposure to arsenic and Cd and specific T cell sub-
populations in cord blood was established in a birth cohort study 
(Nygaard et al., 2017). Moreover, enhanced polyclonal B cell activation 
(PBA) with autoantibody production was induced by oral exposure to 
environmental Cd, which may suggest a common effect of metals in 
nephritis development (Ohsawa 2009). 
Cr(VI) immunotoxicity was also observed by a decrease in lympho-
cytes and an increase in basophils number (Nascimento et al., 2016), as 
well as lymphocyte mitogen-induced proliferation, a decreased density 
of glucocorticoid receptors on peripheral blood mononuclear cells 




Candidate omics-based effect biomarkers identified for Cr(VI) or Cd exposure.  
“Omics”-based effect biomarker Mechanistic relevance and link with health outcome Comments References 
Gene expression 
(transcriptomics) 
Differential expression of genes encoding for proteins involved in critical pathways impacted by Cr(V) or Cd, e. 
g., DNA repair, may be mechanistically associated with exposure and give insights on health outcomes. 
Heavy metals, e.g. Cr and Cd induce oxidative DNA damage. The expression pattern of genes involved in 
detoxification (NQO1, ST13 and MT1A genes) or in DNA repair (OOG1 gene) was associated with environmental 
exposure to Cr and Cd. 
Pros: 
Gene expression may be analysed in blood cells (low invasiveness) 
There is a plausible mechanism of action behind this biomarker 
It has been implemented in human biomonitoring studies 
Transcriptomics may be a high throughput method 
Simple and fast after implementation 
Cons: 
Need of RNA-preserved blood samples 
Molecular biology infrastructures and bioinformatics software 
required Discriminating between adaptive and adverse responses is 
challenging 
More studies needed for specificity, sensitivity and reproducibility 
analyses 
Costs – medium/high – depending on the number of genes analysed; 
sample preservation add cost to the analysis 




Identification of important deregulated pathways after exposure to xenobiotics, can easily be achieved through 
proteomics. 
Hu et al. (2017) showed that 44 significantly differentially expressed serum proteins formed 16 significant 
signaling pathways and a complex proteins-chemical interaction network, which was associated with the 
immune system and extracellular matrix organization. C reactive protein (CRP), sonic hedgehog protein (SHH) 
and calcium were located at critical nodes in proteins-chemical interaction network. CRP and SHH might be 
potential novel biomarkers of Cr(VI) exposure. 
Pros: 
The biomarker may be assessed in serum (low invasiveness) 
There is a plausible mechanism of action behind the biomarker. 
It has been implemented in human biomonitoring studies 
Cons: 
Requires specialized (expensive) equipment and reagents; 
bioinformatic tools 
More studies needed for specificity, sensitivity, and reproducibility 
analyses 
Costs – generally high, depending on the number of proteins analysed 
Hu et al., (2017) 
a, c 
DNA methylation levels 
(epigenomics) 
DNA methylation patterns can be modified by xenobiotics, including Cr(VI) and Cd. Both genomic and 
mitochondrial DNA can be methylated and demethylated and consequently gene expression altered. 
Pros: 
DNA methylation may be analysed in blood cells (low invasiveness) 
No need for sample special preservation beyond storage at − 80 ◦C 
There is a plausible mechanism of action behind this biomarker 
It has been implemented in human biomonitoring studies 
Several methods can be used, e.g., ELISA-based kits or bisulfite 
pyrosequencing (gold standard method) 
Cons: 
Molecular biology infrastructures and bioinformatics software may 
be required 
More studies needed for specificity, sensitivity and reproducibility 
analyses 
Costs – low/high, depending on the method used 
Hu et al., (2018) 
a 
Hossain et al., 
(2012) b 
Zhang et al., 
(2013) b 
Virani et al., 
(2016) b 
5-methylcytosine (5 mC) 
levels in leukocyte DNA 
(epigenomics) 
A methylated cytosine-guanine (CpG) island recovery assay was used to assess over 4.6 million sites spanning 
16,421 CpG islands. 
This study shows distinct patterns of DNA methylation or "footprints" in fetal cord blood and maternal venous 
blood DNA associated with exposure to Cd 
Pros: 
The biomarker may be analysed in blood cells (low invasiveness) 
There is a plausible mechanism of action behind this biomarker 
It has been implemented in human biomonitoring studies 
Possesses high throughput capabilities 
Cons: 
Molecular biology infrastructures and bioinformatics software 
required 
More studies needed for specificity, sensitivity and reproducibility 
analyses Laborious 
Costs – medium/high 




Blood Cr levels were associated with plasma miR-3940-5p level but not with genotoxicity markers. Under high Cr 
exposure, an over expression of miR-3940-5p-regulated DNA repair genes (XRCC2 and BRCC3) was found. It is 
hypothesized that miR-3940-5p modulates genetic damage levels at higher Cr(VI) levels due to the regulation of 
Cr(VI) responsive DNA repair genes expression. 
Pros: 
The biomarkers may be analysed in blood cells (low invasiveness) 
There is a plausible mechanism of action behind this biomarker 
It has been implemented in human biomonitoring studies 
Possesses high throughput capabilities 
Cons: 
Li et al., (2014) 
a 
(continued on next page) 
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(Mignini et al., 2009), and an increased interleukin-6 (IL-6) plasma 
levels (Mignini et al., 2009; Li et al., 2015). Moreover, the later study 
including 84 workers from the shoe, leather, and hide industry, showed 
that Cr(VI) exposure did not modify natural killer cell-mediated cyto-
toxicity, the plasmatic levels of inflammatory cytokines and related 
soluble receptors, and prostaglandin levels, while it tended to increase 
lymphocyte production of immunomodulant cytokines (IFN-γ, IL-4, and 
IL-2). The authors concluded that the characterization of 
mitogen-induced lymphocyte proliferation, glucocorticoid receptors on 
peripheral blood mononuclear cells, and IL-6 plasma levels may allow to 
discriminate between Cr(VI)-induced stress and other kinds of stress 
(Mignini et al., 2009). Lymphocyte proliferative rate and cytokine pro-
duction (IFN-γ, IL-2, IL-4, IL-5, IL-10, IL-12, IL-13, IL-17 and CCL5) were 
also investigated as biomarkers for allergic contact dermatitis in 
chromium-allergic patients (Table 1), but only IL-13 had an accuracy of 
about 90% (Martins and Reis, 2013). 
4.2. Candidate omics-based effect biomarkers 
Exposure to Cr(VI) or Cd can influence gene expression and, conse-
quently, protein expression and metabolism. Expression analysis of 
specific genes involved in the response to xenobiotics, such as detoxi-
fying genes and DNA repair genes, can add valuable information about 
cellular and molecular pathways that are affected by Cr(VI) and Cd 
exposures (Table 2). Furthermore, disruption of these pathways may be 
associated with genotoxicity, carcinogenicity, or other pathological 
processes, and/or may provide mechanistic insights on potential dis-
eases (Ellinger-Ziegelbauer et al., 2009; Schaap et al. 2012, 2014; Li 
et al., 2017). From a practical point of view, gene expression analyses 
can be performed in blood, which is easily collected and allows 
follow-up sampling through time, although it requires proper samples 
preservation after collection to avoid RNA degradation, adding some 
costs., and can be used. High throughput gene expression analyses are 
current but still expensive while for gene-specific approaches the costs 
are reasonable, making these biomarkers good candidates for imple-
mentation (Pizzino et al., 2014). However, finding a specific gene 
signature for each mechanism of toxicity from an initial set of thousands 
of up- or down-regulated genes can be cumbersome, blood may not al-
ways reflect what is happening in target tissues, and few studies using 
gene expression analysis as effect biomarkers for Cr(VI) or Cd exposures 
were retrieved. 
Epigenomics is another recent area of research that has shown 
promising results. Epigenomic changes include histone modifications, 
chromatin remodelling, changes in DNA methylation and changes in 
short non-coding RNAs, including microRNAs (miRNAs). While gene 
transcription is regulated by DNA methylation and chromatin remod-
elling, post-transcriptional gene expression is regulated by e.g. miRNAs. 
These three modes of epigenetic regulation interact in a complex feed-
back network to ultimately determine gene expression (Chung and 
Herceg 2020). Modifications in the epigenome can be measured in many 
types of biological samples, including blood. Moreover, DNA methyl-
ation can be often be measured in biobanked samples without special 
conditions rather than − 80 ◦C. Extracellular circulating miRNAs have 
shown to be remarkably stable in plasma and serum, and resistant to 
RNase activity, as well as extreme pH and multiple numbers of 
freeze-thaw cycles, which favour their potential use as effect biomarkers 
(Chen et al., 2008; Mitchell et al., 2008). As a current limitation, and 
depending on the population size, the costs of analysing DNA methyl-
ation and/or miRNA expression can be high. Overall, both the whole 
genome methylation level and the pattern of DNA methylation of a 
selected set of genes appear as potential effect biomarkers for Cr(VI) or 
Cd exposure (Table 2) that deserve to be further explored. 
Proteomics can be even more robust than transcriptomics, since it 
detects the effect of post-transcriptional and post-translational modifi-
cations that regulate protein quantity and function (for instance, miR-
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high quantities in biological fluids that are easily collected (though some 
with invasive techniques), and a large amount of data can be obtained 
using high-throughput methods, e.g., new mass spectrometry tech-
niques, which allow the detection of low and high molecular weight 
proteins, depending on the number of samples analysed. Thus, proteo-
mic approaches with the improved accuracy of high-throughput tech-
nologies and bioinformatics tools might be an important approach to 
identify protein functional variants associated to metal exposure that 
may be linked to cellular pathways dysfunction and consequent health 
outcomes. Most likely, a signature of deregulated proteins could work as 
an effect biomarker for Cr(VI) or Cd exposures. As an example, in a study 
conducted in 25 Cr-exposed workers and 16 controls from a chromate 
production plant Hu et al. (2017) analysed differentially expressed 
proteins, proteins-chemical interaction networks as well as critical 
proteins nodes related to signalling pathways. The results showed 
regulation of 16 signalling pathways and a complex proteins-chemical 
interaction network, which was associated with the immune system 
and extracellular matrix organization. 
Regarding metabolomics, several human studies were conducted in 
relevant epidemiological settings using proton nuclear magnetic reso-
nance (H NMR) or liquid chromatography/mass spectrometry (LC/MS) 
to detect the specific metabolites, mostly in urine, but also in blood. 
Accordingly, amino acids profiling may be used as a metabolomics effect 
marker as shown in some human and animal studies, as well (Ellis et al., 
2012; Wang et al., 2012; Gao et al., 2014; Dudka et al., 2014; Lee et al., 
2014; Xu et al., 2016; Sarma et al., 2018). As an example, a study re-
ported on the urinary metabolomics profiles of 35 Cr-exposed male 
welders and 16 male office workers at a Taiwanese shipyard. The results 
showed higher levels of glycine, taurine, betaine/TMAO (modulators of 
inflammatory and oxidative tissue injury processes), serine, S-sulfocys-
teine, hippurate, gluconate, creatinine and acetone, and lower levels of 
creatine among welders. Further studies are required in order to link 
metal exposures and classical effect markers with metabolic profiles, as 
well as to provide more data on mechanistic causalities between AO and 
molecular markers. 
4.2.1. Cr(VI) or Cd exposure and genotoxicity 
The literature search conducted for omics-based effect biomarkers 
revealed a highly diverse set of studies (Table 2). In relation to geno-
toxicity, we identified a transcriptomic study of blood samples from 134 
subjects exposed to environmental carcinogens, including Cd. This study 
revealed an association between low exposures to metals and changes in 
expression of DNA repair genes. In addition, the authors reported 
deregulation of carcinogenesis-related pathways using the Comparative 
Toxicogenomics Database (Espin-Perez et al., 2015). Using epigenetic 
approaches, Hu et al. (2018) identified associations between Cr(VI) 
exposure, methylation modification of DNA repair genes and their 
expression levels, and genetic damage in workers. The results of in vitro 
studies using human bronchial epithelial cells exposed to Cr(VI) have 
confirmed positive correlations between methylation levels of tumour 
suppressor genes such as p16 (which encodes a specific inhibitor of 
cyclins being frequently mutated in cancer, including non-small-cell 
lung cancer) and genetic damage (Hu et al., 2016). Additionally, an 
epidemiological study by Y. Li et al. (2014) showed that high blood Cr 
(VI) levels were significantly associated with the decrease of plasma 
miR-3940-5p, which modulated Cr(VI)-induced genetic damage by 
regulating the expression levels of the DNA repair genes XRCC2 and 
BRCC3 in leukocytes (Li et al., 2014). Furthermore, the same authors 
reported that this miRNA has an important role in the regulation of 
double-strand DNA breaks repair in response to lung (16HBE) cells 
exposure to Cr(VI) by enhancing homologous recombination repair (Li 
et al., 2016). Using in vitro and in vivo experiments, Ren et al. (2017) 
were able to further demonstrate that miR-3940-5p over-expression 
inhibits proliferation and induces apoptosis in non-small cell lung cancer 
cells by targeting Cyclin D1 and Ubiquitin Specific Peptidase-28, thus 
having an important protective role of lung cells transformation. Several 
miRNAs have also been shown to be dysregulated in Cd-exposed human 
hepatocellular carcinoma cells (HepG2) and macrophages (THP-1), 
which have been associated with apoptosis and autophagy, respectively, 
and 4 have been proposed as promising biomarkers (Paesano et al., 
2020). A potential biomarker of DNA damage based on long non-coding 
RNA (lncRNA) expression profiling was described in Cr(VI)-treated 
bronchial epithelial cells (Hu et al., 2019). Overall, these findings sug-
gest that epigenetic biomarkers, either based on DNA methylation of 
selected genes or on non-coding RNA analysis, may be considered as 
promising candidate effect biomarkers related to genotoxicity and, 
possibly, to carcinogenicity. 
4.2.2. Cr(VI) or Cd exposure and nephrotoxicity 
Application of epigenetic approaches to detect nephrotoxic effects in 
blood samples from 81 residents in Cd-polluted and non-polluted areas 
revealed that levels of blood and urinary Cd correlated positively with 
the levels of DNA methylation in the gene of the proteohormone KLO-
THO, which inhibits phosphate resorption in the proximal tubules of the 
kidney, and in the tumour suppressor RAS protein activator like 1 
(RASAL1) (Zhang et al., 2013). Hypermethylation of the latter may serve 
as indicator of the progress for chronic kidney disease. Lemaire et al. 
(2020) identified several dysregulated miRNAs in renal proximal 
tubular cell models which may play a role in the pathophysiology of 
Cd-induced kidney damages and may be promising molecular bio-
markers that must be further evaluated. The use of metabolomics may 
also uncover new biomarkers for Cd- and/or Cr-induced effects. Indeed, 
the effects from exposure to environmental Cd correlated with six uri-
nary metabolites, of which three (including citrate) were associated with 
mitochondrial metabolism (Ellis et al., 2012), a pathway also found to 
be affected in Cd-exposed rodents (Lee et al., 2014). These findings are 
in concordance with heavy metal accumulation causing mitochondrial 
dysfunction (see section 5). Other relevant metabolomics studies inde-
pendently confirmed changes in metabolic pathways (Dudka et al., 
2014; Gao et al., 2014; Lee et al., 2014; Sarma et al., 2018). Song et al. 
(2018), using an AKI model in rats, reported that the urinary level of 
semaphorin 3A, a protein secreted in several kidney structures, may be a 
valuable biomarker of early AKI. 
4.2.3. Cr(VI) or Cd exposure and oxidative stress 
For oxidative stress, Pizzino et al. (2014) studied the expression 
levels of detoxifying genes such as NAD(P)H dehydrogenase (quinone 1) 
(NQO1), metallothionein-1A (MT1A) and suppression of tumorigenicity 
13 (ST13), and the DNA repair gene 8-oxoguanine DNA glycosylase 
(OGG1) in an adolescent population exposed to Cr and Cd, among other 
heavy metals, from an industrialized area of Italy. They observed a 
significant upregulation of the genes OGG1 and MT1A, and a slight, but 
not statistically significant, upregulation of the NQO1 and ST13 genes in 
the exposed adolescents compared to non-exposed controls. Likewise, 
oxidative DNA damage, as assessed by urinary 8-OHdG concentration, 
was higher in adolescents exposed to Cr and Cd than in controls. Another 
study reported on the expression levels of inflammatory markers in 
blood of 35 Cr-exposed male welders and 16 controls. The results 
showed that TNF-α gene expression was significantly associated with 
welding fume exposure among all cytokines and inflammatory markers 
measured (Wang et al., 2012). 
5. AOPs development and effect biomarkers 
Cr(VI) exposure via inhalation increases lung cancer risk as the main 
AO, whereas Cd exposure via ingestion primarily targets the kidney, 
leading to nephrotoxicity. It is likely that the MIE for several AOs related 
to heavy metals exposure, including Cr(IV) and Cd, is the binding (of 
metal ions) to thiol containing molecules. KEs such as oxidative stress 
(or increase in ROS), mitochondrial dysfunction, activation of caspases 
(a family of protease enzymes playing essential roles in programmed cell 
death) and apoptosis are common effects upon Cr(VI) and Cd exposure. 
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For Cd and for other heavy metals such as arsenic, lead and mercury, 
they may lead to the AO of tubular damage in the kidney and nephro-
toxicity. KEs as oxidative stress and mitochondrial disruption have also 
been addressed in an AOP for the neurodevelopmental toxicity of 
arsenic, Cd, manganese and lead (Stackelberg et al., 2015). 
In most studies related to Cr(VI) exposure, oxidative stress and direct 
or indirect (ROS-induced) DNA damage have been identified as the two 
major KE underlying genotoxicity. Oxidative stress is probably caused 
by Cr(VI) interference with mitochondrial respiratory chain complex I 
activity (the possible MIE) that leads to mitochondrial dysfunction (Wise 
et al., 2018a; Xiao et al. 2012, 2019). These events are reflected in tissue 
inflammation (Roy et al., 2016) and epithelial-mesenchymal transition 
(Ding et al., 2013; Val et al., 2015), chromosome instability (Wise et al., 
2018b) and malignant transformation of cells (Medan et al., 2012; Val 
et al., 2015; Wang et al., 2011), among other possible KEs. Another KE 
may be the insufficient or incorrect DNA repair, possibly by modulating 
the expression of DNA repair proteins involved in base excision repair or 
in double strand break repair by homologous recombination, as 
observed either in epidemiological studies (Sudha et al., 2011; Long 
et al., 2019) or in in vitro studies using lung cells (Li et al., 2017). 
Additional KEs may be related to apoptosis resistance (Son et al., 2017) 
and endoplasmatic reticulum stress (Ganapathy et al., 2017). Indeed, Cr 
(VI) treatment of human lung epithelial cells or keratinocytes activated 
the intracellular receptor tyrosine kinase SRC, which further upregu-
lated Ras activity, leading to the increase of ROS and the onset of 
endoplasmatic reticulum stress. An AOP has been proposed for Cr(VI) 
and intestinal cancer (Thompson et al., 2013, 2015, 2018). Chronic 
wounding of intestinal villi, chronic regenerative crypt cell hyperplasia 
(Thompson et al., 2013, 2015, 2018), and increase of crypt enterocytes 
were identified as major KEs (Thompson et al., 2015). At the molecular 
level, the same authors identified several changes related to malignant 
transformation of several cell types were reported, involving changes in 
the expression of EGFR, p53, c-Myc, HIF-1 alpha, Bcl-2, PDCD4, FBP1, 
MM1, VEGF, ERK, NF-kB genes and downstream proteins involved in 
cell signalling pathways related to cell division, proliferation, and 
differentiation. 
The strong binding affinity of Cd to methyltransferases or other thiol 
group-containing proteins (Sabolic, 2006; Nordberg et al., 2015) suggest 
several candidates as first KEs (depending on the AO): these include 
oxidative stress, disruption of cadherin-mediated cell-cell adhesion, 
mitochondrial dysfunction, and increase of intracellular calcium (Pro-
zialeck and Edwards 2012; Stackelberg et al., 2015; Bal-Price and Meek, 
2017; Rana et al., 2018). After suffering from mitochondrial damage, 
mitochondrial release of cytochrome C might activate several caspases 
and, subsequently, these caspases trigger apoptosis of cells. Extensive 
cell death in the proximal tubule may lead to proximal tubular damage 
in the kidney. 
Overall, several potential KEs of Cr(VI) or Cd exposure at the mo-
lecular, cellular and tissue level have been identified. However, our 
understanding of the mechanistic relationship with effect biomarkers is 
only partial. Nevertheless, effect biomarkers used in HBM studies are 
informative and at least some of them, e.g., oxidative stress biomarkers 
for Cr(VI) exposure, are associated with likely KE in the AOP framework 
allowing an early identification of biological effects associated with 
adverse health effects, even at population-based subclinical levels. 
Greater efforts should still be made to clarify how different effect bio-
markers are associated with Cr/Cd exposures. Therefore, the results 
need to be interpreted jointly with results of exposure biomarkers, 
particularly the metals internal dose. In general, effect biomarkers are 
not specific of chemicals, but of physiological/pathophysiological 
functions. However, the biological plausibility of the effect biomarkers 
can be improved relying on: i) toxicological knowledge organized 
following an AOP-like conceptualization; ii) evaluate statistical associ-
ations in HBM studies between exposure-effect-outcome designs trying 
to mimic the exposure-MIE-KEs-AO structure. A recent work suggested 
that AOPs may be used in the future to derive effect biomarker-based 
values to address adverse risk levels from chemical exposures (Jeddi 
et al., 2020). To this regard, the development of a list of suitable effect 
biomarkers for regulatory use, as well as recommendations on data 
reporting standardization is needed, in order to ensure the reliability, 
reproducibility and efficiency of effect biomarkers data, as well as the 
transparency in its interpretation, ultimately increasing their utility for 
informing regulatory risk assessment (Jeddi et al., 2020). On the other 
hand, novel omics effect biomarkers may contribute to identify molec-
ular effect biomarkers that can be mechanistically linked to specific 
adverse health effects. Within these new effect biomarkers, analyses of 
gene expression (e.g. of DNA repair and detoxification genes), epige-
netics, as well as proteome and metabolome analyses are feasible. 
Moreover, the combination of a set of classic and omics biomarkers may 
constitute the strongest approach for assessing the potential health ef-
fects of Cr(VI) and Cd. 
6. Conclusions 
To support improved derivation of EU regulation and policy making, 
it is of great importance to identify the most reliable effect biomarkers 
for the heavy metals Cr and Cd that can be used in HBM studies, as they 
could provide evidence of early biological events that can predict (and 
perhaps prevent) adverse health outcomes. In the present study, we 
identified effect biomarkers in epidemiological studies published be-
tween 2008 and 2020. 
For Cr(VI), conventional biomarkers targeting oxidative stress and 
lipid peroxidation (mainly 8-OHdG and MDA), as well as DNA or 
chromosome damage, were the most frequently used to associate 
exposure with cancer development. Despite the high sensitivity of these 
biomarkers, large-scale HBM studies including complementary effect 
biomarkers are still required to better understand the relationships be-
tween exposure and oxidative stress or DNA/chromosome damage 
biomarkers. With respect to Cd and to some extent Cr, β-2-microglobulin 
(B2-MG) and N-acetyl-β-D-glucosaminidase (NAG) are well-established, 
sensitive, and the most commonly used effect biomarkers to relate 
exposure to renal tubular dysfunction. Additionally, NGAL and KIM-1 
could serve as sensitive biomarkers of acute kidney damage in 
response to both Cr(VI) and Cd that needs to be further investigated in 
large HBM studies. 
Overall, there is still insufficient information on the potential health 
effects of chronic low-level Cr(VI) and/or Cd exposure in humans and, in 
particular, a lack of more specific and sensitive (preclinical) biomarkers 
for health effects resulting from this exposure scenario. 
Further development of omics-based biomarkers may help to fill this 
gap. The properties of these novel candidate effect biomarkers need to 
be evaluated for Cr(VI) and Cd exposure and should be validated by 
comparison with established effect biomarkers to (i) determine their 
sensitivity, i.e. whether they can reliably detect differences between 
unexposed and exposed individuals at the low concentrations currently 
present, ii): investigate their specificity (false positive rate), iii) assess 
their predictive value for the adverse outcome, iv) investigate their 
reproducibility, (v) identify possible effects of common confounding 
factors such as smoking, diet, age, sex, and other metal exposures and 
assess their inter- and intra-individual variability; and (vi) evaluate their 
feasibility in terms of speed, cost-effectiveness, and non-invasiveness. 
Nonetheless, high-throughput approaches enable the analysis of tar-
gets at multiple levels (genes, proteins, metabolites) and the identifi-
cation of potential effect-specific profiles that provide relevant 
information on gene networks, cell signaling pathways, and/or biolog-
ical functions, which can advance the (further) elucidation of underlying 
mechanisms. This mechanistic knowledge should then be used to select 
an appropriate set of effect biomarkers. If used in HBM studies along 
with adequate characterization of the environmental or occupational 
setting and exposure biomarkers, such effect biomarkers would 
contribute significantly to better protection of human health. 
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Lebret, E., Olea, N., Sarigiannis, D., Schoeters, G.R., Sepai, O., Tolonen, H., Kolossa- 
Gehring, M., 2017. Human biomonitoring as a tool to support chemicals regulation 
in the European Union. Int. J. Hyg Environ. Health 220, 94–97. https://doi.org/ 
10.1016/j.ijheh.2017.01.007. 
Gao, Y., Lu, Y., Huang, S., Gao, L., Liang, X., Wu, Y., Wang, J., Huang, Q., Tang, L., 
Wang, G., Yang, F., Hu, S., Chen, Z., Wang, P., Jiang, Q., Huang, R., Xu, Y., Yang, X., 
Ong, C.N., 2014. Identifying early urinary metabolic changes with long-term 
environmental exposure to cadmium by mass-spectrometry-based metabolomics. 
Environ. Sci. Technol. 48, 6409–6418. https://doi.org/10.1021/es500750w. 
Gil, F., Hernández, A.F., 2015. Toxicological importance of human biomonitoring of 
metallic and metalloid elements in different biological samples. Food Chem. Toxicol. 
80, 287–297. https://doi.org/10.1016/j.fct.2015.03.025. 
Goyal, T., Mitra, P., Singh, P., Sharma, P., Sharma, S., 2020. Evaluation of oxidative 
stress and pro-inflammatory cytokines in occupationally exposed cadmium workers. 
Work. https://doi.org/10.3233/WOR-203302. 
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